| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |